"L'Ospedale Policlinico San Martino è da sempre un punto di riferimento per le necessità sanitarie dei cittadini dell'area metropolitana genovese e ligure. In cinque secoli di storia l'alto livello e la qualità delle prestazioni offerte hanno richiamato utenti da tutta Italia e dall'estero, contribuendo a rendere questa struttura un importante centro di riferimento."

During the past decade, Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia" are "Chronic Myelomonocytic Leukemia" (1 trials), "DLBCL" (1 trials), "Myelodysplastic-Myeloproliferative Diseases" (1 trials), "T-Cell Lymphoma Refractory" (1 trials) and "T-Cell Lymphoma Relapsed" (1 trials). Many other conditions were trialed in "Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia" in a lesser frequency.

Most popular intervention types in "Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Decitabine" (1 trials), "Ibrutinib" (1 trials) and "Venetoclax" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Policlinico San Martino S.S.R.L. - IRCCS per l'Oncologia - Ematologia, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".